Update on herpes zoster vaccine: Licensure for persons aged 50 through 59 years

Morbidity and Mortality Weekly Report

Volumn 60, Issue 44, 2011, Pages 1528-

  Harpaz, Rafael ^a   Hales, Craig M ^a   Bialek, Stephanie R ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

ARTICLE; FOOD AND DRUG ADMINISTRATION; HERPES ZOSTER; HUMAN; LICENSING; MIDDLE AGED; UNITED STATES;

HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; LICENSURE; MIDDLE AGED; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 81755178307     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. CDC. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2008;57 (No. RR-5).
2. Merck & Co., Inc. Zostavax (package insert). Whitehouse Station, NJ: Merck & Co., Inc.; 2011. Available at http://www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdf Adobe PDF fileExternal Web Site Icon. Accessed November 1, 2011.
3. Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, immunogenicity, safety, and tolerability of zoster vaccine in subjects 50 to 59 years of age. Presented at the 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, Canada, October 21--24, 2010. Available at http://idsa.confex.com/idsa/2010/webprogram/Paper3363.html External Web Site Icon. Accessed November 1, 2011.
4. CDC. Supply of vaccines containing varicella-zoster virus. MMWR 2007;56:146--7.
5. CDC. Update on supply of vaccines containing varicella-zoster virus. MMWR 2007;56:453.
6. Tseng HF, Smith N, Sy LS, Jacobsen SJ. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine 2011;29:3628--32.